Founded in 1992, Guangzhou Wondfo Biotech Co., Ltd. is a global leader in in vitro diagnostic (IVD) solutions, headquartered in Guangzhou Science City, China. Listed on the Shenzhen Stock Exchange since 2015, Wondfo is recognized as the first public POCT company in China, dedicated to advancing rapid diagnostics and chronic disease management.
With nine core technology platforms spanning immunoassay, electrochemistry, dry biochemistry, chemiluminescence, molecular diagnostics, and more, Wondfo delivers a diverse portfolio of products covering cardiovascular, infectious, tumor, fertility, and drug testing. Its renowned Flu Series is the only Chinese product certified for H7 avian influenza antigen detection.
Supported by R&D centers in Guangzhou and San Diego and a global manufacturing and service network across 20+ subsidiaries, Wondfo’s products reach over 150 countries and regions. Guided by the mission to provide professional, innovative, and accessible diagnostic solutions, Wondfo continues to shape the future of global healthcare.
No. 8 Lizhishan Road, Science City, Huangpu, Guangzhou, Guangdong, China